Stock screenerAll disclosures →
EDGAR →
AQST
Conviction 73HealthcareScan · Thu, Jun 25, 2026AQST$4.47-10.52%
ResistanceSupportVol 14Insider sellVol MA14 2.01M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price4.47
Change-10.52%
Gap-2.20%
Rel volume2.66×
Avg volume1.89M
Avg $ vol8.23M
SMA 204.26
SMA 504.22
SMA 2004.89
Price vs 50+5.84%
Price vs 200-8.71%
MA stackmixed
50/200 cross—
Supertrendup · 4.40
RSI (14)54
MACD hist0.07
MACD crossbull · 9d
Stoch %K / %D46 / 75
ADX (14)24
+DI / −DI32 / 29
RSI divergence—
MACD divergence—
ATR %+5.67%
ADR %4.95%
52w high7.49
52w low2.95
From 52w high-40.39%
Above 52w low+51.36%
New 52w highNo
SqueezeOff
Bollinger width32.26%
%B0.65
Donchian pos46.24%
Donchian high5.18
Donchian low3.85
AVWAP (52w high)4.59
vs AVWAP high-2.64%
AVWAP (52w low)4.12
vs AVWAP low+8.37%
OBV trendUp
Chaikin MF (20)0.12
Today vs 20d2.66×
Avg vol (14d)2.01M
Avg vol (20d)1.89M
Avg $ vol (20d)8.23M
Market cap560.13M
RS 3m (vs SPY)+16.35%
RS 6m (vs SPY)-21.70%
RS line new highNo
Trend template4/8
Technical rank41.1
1 week+0.79%
1 month+9.44%
3 months+6.06%
6 months-25.08%
1 year+39.10%
YTD-30.78%
P/E-6.69
P/B-16.45
P/S12.57
P/FCF-10.57
EPS-0.7800
Div yield—
ROE246.03%
ROA-59.37%
Debt/Eq-1.32
Current4.10
EV/EBITDA-7.29
Gross margin—
Net margin-188.09%
Rev growth-22.61%
EPS growth-89.83%
Price target8.17
Target upside82.98%
Analyst ratingBuy
Institutional62.15%
Ent. value494.4M
Revenue14.45M
Net income-8.06M
Gross profit—
Free cash flow-52.99M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out125.45M
Employees147
ListedWed, Jul 25, 2018
Free float99.96M
Float %81.9%
Short interest15.24M
Days to cover10.8d
Short volume57.9%
Squeeze score82 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.07 vs −$0.14
Last surprise+50.0% beat
Setup gradeB
Conviction73 / 100
Pattern quality—
Tech rank41.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.73
Support3.85
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AQST
No recent disclosed trades by Congress in AQST. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AQST · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Krop Julie Director · Common Stock · 2026-06-23 | Exercise | 25K | $18K | 2026-06-23 | 2026-06-24 |
Krop Julie Director · Non-Qualified Stock Option (right to buy) · 2026-06-23 | Exercise | 25K | — | 2026-06-23 | 2026-06-24 |
Krop Julie Director · Common Stock · 2026-06-23 | Sell | 25K | $125K | 2026-06-23 | 2026-06-24 |
Barber Daniel President and CEO · Common Stock · 2026-06-15 | Sell | 25K | $104K | 2026-06-15 | 2026-06-16 |
Taglietti Marco Director · Stock Option (Right to Purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
BROWN GREGORY B Director · Stock Option (Right to Purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
Cochran John Director · Stock Option (Right to Purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
Jenkins Abigail L. Director · Non-Qualified Stock Option (right to buy) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
Krop Julie Director · Stock Option (Right to Purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
MORRIS TIMOTHY E Director · Stock Option (right to purchase) · 2026-06-10 | Grant | 50.5K | — | 2026-06-10 | 2026-06-12 |
SEC filings
EDGAR filings in AQST · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.